Nothing Special   »   [go: up one dir, main page]

SG10201702454YA - Addition of iron to improve cell culture - Google Patents

Addition of iron to improve cell culture

Info

Publication number
SG10201702454YA
SG10201702454YA SG10201702454YA SG10201702454YA SG10201702454YA SG 10201702454Y A SG10201702454Y A SG 10201702454YA SG 10201702454Y A SG10201702454Y A SG 10201702454YA SG 10201702454Y A SG10201702454Y A SG 10201702454YA SG 10201702454Y A SG10201702454Y A SG 10201702454YA
Authority
SG
Singapore
Prior art keywords
iron
addition
cell culture
improve cell
improve
Prior art date
Application number
SG10201702454YA
Other languages
English (en)
Inventor
Wenge Wang
Yen-Tung Luan
Denis Drapeau
Ryan P Nolan
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47324213&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201702454Y(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of SG10201702454YA publication Critical patent/SG10201702454YA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0681Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00Cells for large scale production

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
SG10201702454YA 2011-10-21 2012-10-09 Addition of iron to improve cell culture SG10201702454YA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161550058P 2011-10-21 2011-10-21

Publications (1)

Publication Number Publication Date
SG10201702454YA true SG10201702454YA (en) 2017-05-30

Family

ID=47324213

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201702454YA SG10201702454YA (en) 2011-10-21 2012-10-09 Addition of iron to improve cell culture
SG11201401220SA SG11201401220SA (en) 2011-10-21 2012-10-09 Addition of iron to improve cell culture

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201401220SA SG11201401220SA (en) 2011-10-21 2012-10-09 Addition of iron to improve cell culture

Country Status (17)

Country Link
US (1) US20140322758A1 (da)
EP (1) EP2768944B2 (da)
JP (1) JP6400473B2 (da)
KR (2) KR20170021919A (da)
CN (1) CN103890166A (da)
AU (1) AU2012324495B2 (da)
BR (1) BR112014009379A2 (da)
CA (1) CA2852021C (da)
DK (1) DK2768944T3 (da)
ES (1) ES2784146T5 (da)
HK (1) HK1198657A1 (da)
IL (1) IL232171B (da)
MX (1) MX351991B (da)
RU (1) RU2663794C2 (da)
SG (2) SG10201702454YA (da)
WO (1) WO2013057628A1 (da)
ZA (1) ZA201402490B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102604992B1 (ko) * 2017-03-31 2023-11-24 베링거 인겔하임 인터내셔날 게엠베하 관류 배지
EP4368698A1 (en) * 2022-11-09 2024-05-15 Sciperio, Inc. Optimized cell culture medium utilizing iron (iii) citrate as an iron delivery method for the in vitro, bioreactor-centric production of manufactured blood
KR102701166B1 (ko) * 2023-12-01 2024-09-02 주식회사 한풍네이처팜 코리네박테리움 글루타미쿰 Hemo-P1 균주를 이용한 헴철 생산 방법

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5166320A (en) 1987-04-22 1992-11-24 University Of Connecticut Carrier system and method for the introduction of genes into mammalian cells
US6291159B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for producing polymers having a preselected activity
JPH0396383A (ja) 1989-09-08 1991-04-22 Riso Kagaku Corp 画像形成装置
DK0417563T3 (da) 1989-09-12 2000-11-06 Hoffmann La Roche TNF-bindende proteiner
ATE168416T1 (de) 1989-10-05 1998-08-15 Optein Inc Zellfreie synthese und isolierung von genen und polypeptiden
US6657103B1 (en) 1990-01-12 2003-12-02 Abgenix, Inc. Human antibodies derived from immunized xenomice
GB9021679D0 (en) 1990-10-05 1990-11-21 Gorman Scott David Antibody preparation
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
DE4115722A1 (de) * 1991-05-14 1992-11-19 Boehringer Mannheim Gmbh Serumfreies medium zur kultivierung von saeugerzellen
WO1993000423A1 (en) * 1991-06-21 1993-01-07 Novo Nordisk A/S Iron chelate culture medium additive
GB9215834D0 (en) 1992-07-24 1992-09-09 Celltech Ltd Cell culture
US6310185B1 (en) 1994-03-08 2001-10-30 Memorial Sloan Kettering Cancer Center Recombinant human anti-Lewis Y antibodies
AU4330597A (en) * 1996-08-30 1998-03-19 Life Technologies, Inc. Serum-free mammalian cell culture medium, and uses thereof
TW200526779A (en) 2001-02-08 2005-08-16 Wyeth Corp Modified and stabilized GDF propeptides and uses thereof
WO2003072714A2 (en) 2002-02-21 2003-09-04 Wyeth Follistatin domain containing proteins
MXPA04008150A (es) 2002-02-21 2005-06-17 Wyeth Corp Gasp1: una proteina que contiene dominio de folistatina.
SG165158A1 (en) 2002-05-02 2010-10-28 Wyeth Corp Calicheamicin derivative-carrier conjugates
US7261893B2 (en) 2002-10-22 2007-08-28 Wyeth Neutralizing antibodies against GDF-8 and uses therefor
US20040223966A1 (en) 2002-10-25 2004-11-11 Wolfman Neil M. ActRIIB fusion polypeptides and uses therefor
KR20060076781A (ko) 2003-09-18 2006-07-04 레이븐 바이오테크놀로지스, 인코퍼레이티드 세포 배양 배지
TWI364458B (en) * 2004-08-27 2012-05-21 Wyeth Res Ireland Ltd Production of tnfr-lg
WO2006047380A2 (en) 2004-10-22 2006-05-04 Amgen, Inc. Method and media for single cell serum-fee culture of cho cells
EA011749B1 (ru) * 2004-11-02 2009-06-30 Арес Трейдинг С.А. Способ продуцирования гормона роста человека и применение среды, не содержащей сыворотки, для культивирования клеток млекопитающих, экспрессирующих гормон роста человека
US20070190057A1 (en) 2006-01-23 2007-08-16 Jian Wu Methods for modulating mannose content of recombinant proteins
MY185887A (en) * 2006-09-13 2021-06-14 Abbvie Inc Cell culture improvements
WO2009087087A1 (en) * 2008-01-09 2009-07-16 Cellca Gmbh Improved culture media additive and process for using it
EP2331678B1 (en) * 2008-06-13 2015-09-30 Janssen Biotech, Inc. Methods for obtaining high viable cell density in mammalian cell culture
CN102021139A (zh) * 2009-09-11 2011-04-20 华东理工大学 一种中国仓鼠卵巢细胞培养基及其制备方法和应用

Also Published As

Publication number Publication date
US20140322758A1 (en) 2014-10-30
DK2768944T3 (da) 2020-04-20
MX351991B (es) 2017-11-03
JP6400473B2 (ja) 2018-10-03
EP2768944A1 (en) 2014-08-27
ES2784146T3 (es) 2020-09-22
EP2768944B1 (en) 2020-02-26
MX2014004735A (es) 2014-07-28
KR20140077977A (ko) 2014-06-24
AU2012324495A1 (en) 2014-04-24
ZA201402490B (en) 2015-11-25
EP2768944B2 (en) 2023-11-22
HK1198657A1 (en) 2015-05-22
CA2852021A1 (en) 2013-04-25
AU2012324495B2 (en) 2016-04-21
IL232171A0 (en) 2014-06-30
BR112014009379A2 (pt) 2017-04-18
JP2014530620A (ja) 2014-11-20
ES2784146T5 (es) 2024-06-04
CN103890166A (zh) 2014-06-25
SG11201401220SA (en) 2014-07-30
RU2014115731A (ru) 2015-11-27
KR20170021919A (ko) 2017-02-28
CA2852021C (en) 2018-08-28
WO2013057628A1 (en) 2013-04-25
RU2663794C2 (ru) 2018-08-09
IL232171B (en) 2018-07-31

Similar Documents

Publication Publication Date Title
IL288509A (en) Mammalian cell culture
HK1199905A1 (en) Culturing of mesenchymal stem cells
EP2651207A4 (en) METHOD FOR IMPROVING THE COMPETENCE OF PLANT CELLS
EP2729561A4 (en) CELL CULTURE METHOD
GB201213868D0 (en) Improvements in or relating to methods of manufacture
SG11201503579RA (en) Cell culture med
GB201110042D0 (en) Growth of cells
EP2799538A4 (en) DIFFERENTIATION INDUCTION METHOD FOR PREVENTING TUMORIGENE TRANSFORMATION OF INDUCED PLURIPOTENT STEM CELLS (SPI)
EP2714709A4 (en) CELL-BASED AND GENE-BASED METHODS FOR ENHANCING CARDIAC FUNCTION
IL231663A0 (en) Vaccines directed at presenting dendritic cells
EP2683411A4 (en) METHODS OF USING MICROARN-26A FOR PROMOTING ANGIOGENESIS
GB2489486B (en) Improvements relating to construction
HK1198657A1 (en) Addition of iron to improve cell culture
EP2699672A4 (en) METHOD FOR PRODUCING VIRUSES IN CULTURED CELLS
IL227930A0 (en) cell division enhancer
HUP1100092A2 (en) Arrangement for production and using of biogas
GB201116456D0 (en) Improvements relating to foorwear
GB201103718D0 (en) Isolation of cells
GB201000585D0 (en) Brickers aid to pillars